REFERENCIAS

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics 2021. CA: a cancer journal for clinicians. 2021;71(1):7-33. https://doi.org/10.3322/caac.21654 [ Links ]

2. Sundar S, Balega J, Crosbie E, Drake A, Edmondson R, Fotopoulou C, et al. BGCS uterine cancer guidelines: Recommendations for practice. Eur J Obstet Gynecol Reprod Biol. 2017 Jun;213:71- 97. doi: 10.1016/j.ejogrb.2017.04.015 [ Links ]

3. Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;12;387(10023):1094-108. doi: 10.1016/S0140-6736(15)00130-0 [ Links ]

4. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009 Jul;114(1):121-7. doi: 10.1016/j.ygyno.2009.03.039 [ Links ]

5. Prueksaritanond N, Angsathapon S, Insin P. The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer. Gynecol obstet investig. 2023;88(1):53-60. https://doi.org/10.1159/000528851 [ Links ]

6. Tam SJ, Watts RJ. Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier. Ann rev neurosci. 2010;33:379-408. doi: 10.1146/annurev-neuro-060909-152829 [ Links ]

7. Tadagavadi RK, Wang W, Ramesh G. Netrin-1 regulates Th1/ Th2/Th17 cytokine production and inflammation through UNC5B receptor and protects kidney against ischemia-reperfusion injury. J Immunol. (Baltimore, Md : 1950). 2010;185(6):3750-8. doi: 10.4049/jimmunol.1000435 [ Links ]

8. Han P, Fu Y, Liu J, Wang Y, He J, Gong J. Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma. Am J Cancer Res. 2015 Mar 15;5(4):1396-409. [ Links ]

9. Zhang X, Cui P, Ding B, Guo Y, Han K, Li J, et. al. Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction. Cancer Gene Ther. 2018 Feb;25(1-2):18-26. doi: 10.1038/s41417-017-0008-8 [ Links ]

10. Li B, Shen K, Zhang J, Jiang Y, Yang T, Sun X, Ma X, Zhu J. Serum netrin-1 as a biomarker for colorectal cancer detection. Cancer Biomark. 2020;28(3):391-6. doi: 10.3233/CBM-190340 [ Links ]

11. Zhao Y, Song J, Ding X, Hao Y, Cao L. Detection of netrin-1 as a novel biomarker for diagnosis and chemotherapeutic monitoring of lung cancer. J Int Med Res. 2022 Jun;50(6):3000605221105364. doi: 10.1177/03000605221105364 [ Links ]

12. Yuan M, Xie F, Xia X, Zhong K, Lian L, Zhang S, et. al. UNC5C-knockdown enhances the growth and metastasis of breast cancer cells by potentiating the integrin a6/ß4 signaling pathway. Int J Oncol. 2020 Jan;56(1):139-50. doi: 10.3892/ijo.2019.4931 [ Links ]

13. Rousset-Rouviere S, Rochigneux P, Chrétien AS, Fattori S, Gorvel L, Provansal M, et al. Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology. Biomedicines. 2021 Jun 2;9(6):632. doi: 10.3390/biomedicines9060632 [ Links ]

14. Kato H, Zhou Y, Asanoma K, Kondo H, Yoshikawa Y, Watanabe K, et al. Suppressed tumorigenicity of human endometrial cancer cells by the restored expression of the DCC gene. Br J Cancer. 2000 Jan;82(2):459-66. doi: 10.1054/bjoc.1999.0943 [ Links ]

15. Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, Scoazec JY, et al. The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4173-8. doi: 10.1073/pnas.0738063100 [ Links ]

16. Costas L, Frias-Gomez J, Guardiola M, Benavente Y, Pineda M, Pavón MÁ, et al. New perspectives on screening and early detection of endometrial cancer. Int J Cancer. 2019 Dec 15;145(12):3194-206. doi: 10.1002/ijc.32514 [ Links ]

17. Townsend MH, Ence ZE, Felsted AM, Parker AC, Piccolo SR, Robison RA, et al. Potential new biomarkers for endometrial cancer. Cancer Cell Int. 2019 Jan 21;19:19. doi: 10.1186/s12935-019-0731-3 [ Links ]

18. Lai Wing Sun K, Correia JP, Kennedy TE. Netrins: versatile extracellular cues with diverse functions. Development (Cambridge, England). 2011;138(11):2153-69. doi: 10.1242/dev.044529 [ Links ]

19. Yin K, Dang S, Cui L, Fan X, Wang L, Xie R, et al. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity. Biochem Biophys Res Commun. 2018 Jan 29;496(1):76-82. doi: 10.1016/j.bbrc.2017.12.170 [ Links ]

20. Kato HD, Kondoh H, Inoue T, Asanoma K, Matsuda T, Arima T, et al. Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis. Gynecol Oncol. 2004 Nov;95(2):281-9. doi: 10.1016/j.ygyno.2004.07.050 [ Links ]

21. Frees S, Zhou B, Han KS, Tan Z, Raven P, Wong A, et al. The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib. Oncotarget. 2018 Apr 27;9(32):22631-41. doi: 10.18632/oncotarget.25201 [ Links ]

22. Yin K, Wang L, Zhang X, He Z, Xia Y, Xu J, et al. Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway. Oncotarget. 2017 May 10;8(31):51177-89. doi: 10.18632/oncotarget.17750 [ Links ]

23. Cassier PA, Navaridas R, Bellina M, Rama N, Ducarouge B, Hernandez-Vargas H, et al. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer. Nature. 2023 Aug;620(7973):409-16. doi: 10.1038/s41586-023-06367-z [ Links ]

24. Mohamed R, Liu Y, Kistler AD, Harris PC, Thangaraju M. Netrin-1 Overexpression Induces Polycystic Kidney Disease: A Novel Mechanism Contributing to Cystogenesis in Autosomal Dominant Polycystic Kidney Disease. Am J Pathol. 2022;192(6):862- 75. doi:10.1016/j.ajpath.2022.03.004 [ Links ]

25. Alowayed N, Salker MS, Zeng N, Singh Y, Lang F. LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2016;39(3):815-26. doi: 10.1159/000447792 [ Links ]

26. El-Gamal R, Mokhtar N, Ali-El-Dein B, Baiomy AA, Aboazma SM. Netrin-1: A new promising diagnostic marker for muscle invasion in bladder cancer. Urol oncol. 2020;38(7):640.e1-.e12. doi: 10.1016/j.urolonc.2020.02.006 [ Links ]